Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion ↧ ↧ Australia's Telix Pharma agrees to buy Germany's ITM Isotope for ab... Australia's Telix Pharmaceuticals said on Monday it ‌has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis, further boosting its radiopharmaceutical ​ambitions.